Evidence map›Paper›PMID 40469981›Full record

ReviewFrontiers in pharmacology2025

Vitamin B5 and vitamin U review: justification of combined use for the treatment of mucosa-associated gastrointestinal pathologies.

Valentin P Shichkin

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Valentin P ShichkinAktipharm LLC, Kyiv, Ukraine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory and erosive lesions of the gastrointestinal mucosa encompass many conditions presenting significant challenges to public health worldwide. Amidst the quest for effective treatments, the attention of researchers has turned towards the potential therapeutic impact of bioactive nutrients, notably vitamin B5 (pantothenic acid) and vitamin U (S-methylmethionine). This review delves into the current understanding of the impact of these vitamins on the gastrointestinal system, analyzing their mechanisms of action and giving clinical evidence of the effectiveness of the combined application of these vitamins in the management of erosive gastrointestinal diseases.

Indexed as

erosive lesionsgastrointestinal mucosainflammationpantothenic acidS-methylmethioninevitamin B5vitamin U

Identifiers

PMID40469981
PMCPMC12133511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.